Welcome to LookChem.com Sign In|Join Free

CAS

  • or

249647-25-4

Post Buying Request

249647-25-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

249647-25-4 Usage

Chemical Properties

White powder

Check Digit Verification of cas no

The CAS Registry Mumber 249647-25-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,9,6,4 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 249647-25:
(8*2)+(7*4)+(6*9)+(5*6)+(4*4)+(3*7)+(2*2)+(1*5)=174
174 % 10 = 4
So 249647-25-4 is a valid CAS Registry Number.

249647-25-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Bromo-4-iodobenzoic acid

1.2 Other means of identification

Product number -
Other names 3-bromo-4-iodo-benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:249647-25-4 SDS

249647-25-4Relevant articles and documents

Selective catalytic behavior of a phosphine-tagged metal-organic framework organocatalyst

Xu, Xiaoying,Rummelt, Stephan M.,Morel, Flavien L.,Ranocchiari, Marco,Van Bokhoven, Jeroen A.

supporting information, p. 15467 - 15472 (2016/02/18)

Steric hindrance by a metal-organic framework (MOF) is shown to influence the outcome of a catalytic reaction by controlling the orientation of its intermediates. This is demonstrated using an organocatalyst, phosphine MOF LSK-3, which is evaluated with t

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065

-

Page/Page column 73, (2009/05/28)

The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1

Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70

Vu, Chi B.,Corpuz, Evelyn G.,Merry, Taylor J.,Pradeepan, Selvaluxmi G.,Bartlett, Catherine,Bohacek, Regine S.,Botfield, Martyn C.,Eyermann, Charles J.,Lynch, Berkley A.,MacNeil, Ian A.,Ram, Mary K.,Van Schravendijk, Marie Rose,Violette, Shelia,Sawyer, Tomi K.

, p. 4088 - 4098 (2007/10/03)

A series of 1,2,4-oxadiazole analogues has been shown to be potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70, a potential therapeutic target for immune suppression. These compounds typically are 200- 400-fold more potent than the native,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 249647-25-4